i t i s t h o u g h t t h a t t h e l o c a l~n o f~o p h j l d g i v e d~b a s i c~d u r i s g t h e L P R~~l l t r i i t o t h ~e p i t h e l i a l~a n d l u n g i n t h m m n t i n n f o u Q d i n ~( 4 ) . T h e L P R m a y b c w l e t a i a e d b y~t i n g c e l l a t h t l t beorstlrfrrcaboundIgE aad
h after the immediate reection begins to suthen is fie q u c l l t l y t h e 0 n s e t o f a n i n~~~n , t g m a the phase rcspoum' ' (LPR). T b is associated with the expnssion oflaakoq&dtmion moiecuks on the local vascular cidotwium aad the co-t inmation of ~~ ncmtrophils, and mq~wuclear ails (2, 3). This I&mcdiated LPR is thought to play a withal role in the of
Ulrrh~vitynadiolldepEndontheeJaentofthenac-t i o n d~i o c a t~o f m a s t c d l~t i o n .
It has become incnasingly appmhted that the JgBrncdiated LPR plays sn impmfmt role in the pathogenesis of chronic a k q i c dizrPaPa such as rwthma, AD, and alkrgic rhinitin For involved in the regulation of B-cell activation and growth. One possibility that has been suggested is that T cells express a ligand for CWO on activation. This would implicate CD40 in noncognate, contactdependent Tcell interactions.
~p l e , i t i s t h o u g h t t h a t t h e l o c a l~n o f~o p h j l d g i v e d~b a s i c~d u r i s g t h e L P R~~l l t r i i t o t h ~e p i t h e l i a l~a n d l u n g i n t h m m n t i n n f o u Q d i n ~( 4 ) . T h e L P R m a y b c w l e t a i a e d b y~t i n g c e l l a t h t l t beorstlrfrrcaboundIgE aad can tberefare rdae Cytokhmand ~o n~t o s p o c i t i c a l k g c m T h e i m~0 tbeLPRisfurllrcrruppclrtedbytheobscrvationtbatthehtcdty
Hydrocortisone has been found to upregulate -dent IgE synthesis by normal unhctionated mononuclear cells (33). These observations have been extended to demonstrate that sIgE-B-fiomnonatopic W m c a n b e i n d d t o s y nIgE when incubated with a combination of hydrocortisone and rIL-4 (34). The mechanisms by which hydrocortisone synergizes with IL-4 are unknown. However, these in vitro observations provide an immunologic basis for the in vivo studies, which demonstrate that atopic individuals frequently have an inmaw in serum IgE during the Grst 2 wk after systemic steroid therapy.
Taken together, these data indicate that the second signal(s) required for IgE produ&on can be delivered to B cells through different activation pathways. In particular, it has k n shown that anti-CD40 MAb and CD4+ T-cell clones act ~5 t h rIL-4 to induce IgE switching in p d e d B cells via different signaling pathways (32). The exact mechanisms by which diverse signals such as T cells, EBV, hydrocortisone, and anti-CD40 stimulate I@ synthesis in the presence of rIL-4 remain to be elucidated. It is possible, however, that these different pathways will share the ability to activate switch recombination in B cells that have been incubated with IL-4 to render the 0 locus accessible.
MODULATION OF IgE SYNTHESIS BY CYTOKINES
Although IL-4 is critical for the induction of I@ synthesis, other cytokines have been found to modulate IL-4-induced IgE synthesis. In particular, IG5, a nonisotype-specific B-cell growth factor (44), and IL-6, a B e l l differentiation factor, upregulate IgE synthesis induced by IL-4 in PBMC (25). Indeed, endogenous I M seems to be critical for IL-4-induced IgE synthesis in PBMC, inasmuch as anti-IL-6 antibody strongly inhibits the production of IgE in such cultures. In contrast, I L I and tumor n factor-a have no effect on this response. Although some l a x tories have reported that IL2 enhances W i n d u c e d IgE synthesis, others have found no significant effect.
m, IFN-a, and transforming growth factor4 have been reported to suppress W i n d u c e d IgE synthesis in experimental animals and humans (45-48). Of these three cytokines, FI+y has been studied most extensively for its capacity to inhibit IgE synthesis in vitro and in vivo. The capacity of human and mouse T-cell clones to induce IgE synthesis has been found to be directly correlated with the ratio of secreted IL-4 to IFNy (47). IFNq also antagonizes the effects of IL-4 in other systems, e.g. IFNq has been reported to inhibit the IL4dependent induction of CD23 on B cells (49). Of particular interest is the finding that the production of IFWy is down-regulated by 50) . The capacity of IL-4 to induce IgE synthesis thus may reflect not only its ability to induce germline c transcripts but also its ability to suppress the production of IFI%y, a potent antagonist of IL-4 These data suggest that the capacity of IFN7 to inhibit IgE synthesis may depend on the pathway of B-cell activation. Furthermore, the possibility remains that I F W may act indirectly on T cells to either down-regulate IL-4 production or induce the production of another cytokine that can inhibit IgE synthesis.
COMPARTMENTALIZATION OF T CELLS
BY CYTOKINE PROFILES In 1986, Mosmann et al. (52) described two distinct types of cloned mouse helper T-cell lines that were defined primarily by differences in the pattern of lymphokines synthesized. THI but not TH2 cells produce IL2, EWy, and lymphotoxin, whereas TH2 but not TH1 cells produce IL-4, IL5, IL-6, and ILlO (53).
IL3 and granulwmacrophage colony stimulating factor are secreted by both types. TH1 and TH2 cells have been reported to remain well defined and functionally; stable, at least in tissue 
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